로딩 중…
지수 로딩 중…
Wooree Bio Co.,Ltd
082850· KOSDAQ· Information Technology· Semiconductors & Semiconductor Equipment
₩4,655-1.06%
2026-09-18
Financials
Valuation Metrics
Wooree Bio Co.,Ltd's Market Cap is ₩451B. At end of 2025 it was ₩986B. Ranked #1832 of 2,421 in KR market (top 76%), #1126 of 1,640 on KOSDAQ (top 69%), #177 of 214 in Semiconductors & Semiconductor Equipment (top 83%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 45.11B KRW | KR#1,832/2,421 Sec#177/214 |
| Revenue | 1.10T KRW | KR#385/2,421 Sec#9/214 |
| Net Income | -1.85B KRW | KR—/2,421 Sec—/214 |
| Total Assets | 873.08B KRW | KR#517/2,421 Sec#18/214 |
| Net Assets | 263.32B KRW | KR#791/2,421 Sec#61/214 |
| Employees | 90 | KR#1,721/2,421 Sec#163/214 |
| Value | ||
| P/B | 0.17x | KR#86/2,421 Sec#4/214 |
| P/S | 0.04x | KR#17/2,421 Sec#1/214 |
| FCF Yield | 28.76% | KR#197/2,421 Sec#4/214 |
| Profitability | ||
| ROE | -0.70% | KR#1,600/2,421 Sec#138/214 |
| ROA | -0.21% | KR#1,574/2,421 Sec#137/214 |
| Op. Margin | -0.38% | KR#1,636/2,421 Sec#138/214 |
| Revenue Growth | -5.78% | KR#1,808/2,421 Sec#158/214 |
| Financial Health | ||
| Debt Ratio | 231.57% | KR#2,171/2,421 Sec#203/214 |
| Total Debt | 270.09B KRW | KR#441/2,421 Sec#23/214 |
| FCF | 12.98B KRW | KR#642/2,421 Sec#50/214 |
| Cash | 0 KRW | KR—/2,421 Sec—/214 |
| Current Ratio | 1.15x | KR#1,550/2,421 Sec#148/214 |
| Dividend | ||
| Div. Yield | 2.15% | KR#844/2,421 Sec#26/214 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/214 |
| Performance | ||
| 1Y Return | -61.77% | KR#2,227/2,421 Sec#208/214 |
| 1M Return | 3.79% | KR#853/2,421 Sec#105/214 |
| From 52W High | -65.20% | KR#2,041/2,421 Sec#180/214 |
| 1Y MDD | -65.22% | KR#1,761/2,421 Sec#137/214 |
| Trading | ||
| Volume | 13,958 shares | KR#1,774/2,421 Sec#195/214 |
| Trading Value | 64.8M KRW | KR#1,745/2,421 Sec#187/214 |
| Foreign Own. | 2.27% | KR#1,538/2,421 Sec#160/214 |
| Per Share | ||
| EPS | -191 KRW | KR—/2,421 Sec—/214 |
| BPS | 27,170 KRW | KR#416/2,421 Sec#17/214 |
Company Info
동사는 2000년 설립, 2005년 코스닥에 상장되었으며 국내 4개 법인과 중국, 베트남, 미국 등 9개 해외 법인 운영 중임. 건강기능식품, LED PKG, SMT, LED BLU 등의 전자부품을 제조, 판매하며 솔루티오 등 독자 브랜드로 리포좀 공법 적용한 차별화 제품 공급함. FPCB 사업은 신제품 개발, 품질 향상, 원가 경쟁력 강화로 BLU 중심 구조에서 일반산업용 제품으로 확장하고 있음. 우리바이오는 2000년에 설립되었으며 경기도 안산시에 본사를 두고 있습니다.